Hailing Lu

Harbin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Development of machine learning-based prognostic models for small cell lung cancer with brain metastases: an analysis of SEER and Chinese populations.

Development of machine learning-based prognostic models for small cell lung cancer with brain metastases: an analysis of SEER and Chinese populations.

Journal: Journal of thoracic disease

Published: May 12, 2025

Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma.

Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma.

Journal: International journal of biological sciences

Published: January 28, 2023

Author Correction: MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC.

Author Correction: MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC.

Journal: Scientific reports

Published: December 15, 2022

Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial.

Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial.

Journal: BMC cancer

Published: December 13, 2022

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.

Journal: Frontiers in cell and developmental biology

Published: March 18, 2020

Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.

Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.

Journal: Frontiers in oncology

Published: March 11, 2020

Systemic administration with tetrahydrocannabinol causes retinal damage in BALB/c mice.

Systemic administration with tetrahydrocannabinol causes retinal damage in BALB/c mice.

Journal: Human & experimental toxicology

Published: November 05, 2019

USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression.

USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression.

Journal: Aging

Published: September 27, 2019

Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.

Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.

Journal: Oncogene

Published: April 22, 2019

Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.

Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 17, 2019

miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.

miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.

Journal: Stem cell research & therapy

Published: August 22, 2018

USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.

USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.

Journal: Cancer letters

Published: April 23, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026